TGFB1 and cancer: TGF-β signaling via the TGF-βRI–TGF-βRII receptor complex is central to numerous biological processes; thus, over the years, there has been a keen interest in developing therapeutic interventions to disrupt the formation this receptor complex for treating cancer [58,59] and certain autoimmune diseases [60,61].